State Street’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-673
Closed -$2.88K 4302
2025
Q4
$2.88K Hold
673
﹤0.01% 4284
2025
Q3
$7.96K Hold
673
﹤0.01% 4272
2025
Q2
$14.6K Hold
673
﹤0.01% 4222
2025
Q1
$17.8K Hold
673
﹤0.01% 4220
2024
Q4
$41.6K Buy
+673
New +$39K ﹤0.01% 4134
2024
Q1
Sell
-261
Closed -$35.4K 4382
2023
Q4
$35.4K Hold
261
﹤0.01% 4258
2023
Q3
$50.3K Hold
261
﹤0.01% 4288
2023
Q2
$53.9K Hold
261
﹤0.01% 4400
2023
Q1
$65.1K Sell
261
-187
-42% -$52.5K ﹤0.01% 4436
2022
Q4
$106K Hold
448
﹤0.01% 4353
2022
Q3
$183K Buy
448
+389
+659% +$224K ﹤0.01% 4186
2022
Q2
$18K Hold
59
﹤0.01% 4884
2022
Q1
$25K Buy
59
+1
+2% +$795 ﹤0.01% 4870
2021
Q4
$79K Hold
58
﹤0.01% 4618
2021
Q3
$94K Hold
58
﹤0.01% 4560
2021
Q2
$109K Buy
+58
New +$113K ﹤0.01% 4344

Other funds holding GOVX

State Street's GOVX Position: Q1 2026 in Review

State Street sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 673 shares — an estimated $2.88K sold.

State Street first reported a position in GOVX in Q2 2021 and held it in 16 quarters. The position peaked at $183K in Q3 2022. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

  • State Street reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
  • State Street sold 673 GeoVax Labs shares in Q1 2026, an estimated $2.88K.
  • State Street first reported a position in GeoVax Labs in Q2 2021 and held it in 16 quarters.
  • State Street's GeoVax Labs position peaked at $183K in Q3 2022.
  • 16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.